A dated PPWR roadmap for patch pouches and cartons, including 2026 application, 2030 minimisation and medical-packaging exceptions.
Eight evidence-based questions for auditing a patch OEM after FDA QMSR took effect on February 2, 2026.
How to plan ICH Q1A shelf-life studies for drug patches using three batches, market packaging and justified stability tests.
An ICH Q1B decision path for testing a patch outside its pouch, in the immediate pack and in the marketing pack.
Microneedle patches use 50-2000 micrometer needles to deliver proteins, peptides, and vaccines painlessly. Dissolving microneedles deliver 9...
Transdermal patch patents grew 18% annually from 2020-2024. Microneedles lead with 2,840 filings, followed by controlled-release matrices, h...
Phase-change materials deliver consistent 40-55°C therapeutic heat for 4-8 hours without the oxygen-dependent reaction of iron-powder patche...
Smart hydrogel patches respond to environmental stimuli (pH, temperature, glucose) for on-demand drug release. Market projected to grow from...
Biodegradable patch materials including PLA backing film, bamboo non-woven, plant-based adhesives, and paper release liners reduce environme...
Global pain relief patch market reaches USD 4.8B in 2024, projected USD 7.6B by 2030 at 7.9% CAGR. China leads manufacturing with 300+ expor...
QQ: 396269538
Phone: 17796669065
Tel: 17796669065
Email: 396269538
Add: Room 001, 1st Floor, Building 1, Zhengzhou Hangmei International Smart City, Intersection of S102 and Nanquan Road, Xuedian Town, Xinzheng City, Zhengzhou, Henan Province, China